Chen, R. T., Markowitz, L. E., Albrecht, P., Stewart, J. A., Mofenson, L. M., Preblud, S. R. & Orenstein, W. A. (1990). Measles antibody: reevaluation of protective titers. J Infect Dis 162, 1036-42. Cherry, J., Feigin, R., Schackelford, P., Hinthorn, D. & Schimidt, R. (1973). A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr 82, 802-8. Chibo, D., Birch, C. J., Rota, P. A. & Catton, M. G. (2000). Molecular characterization of measles viruses isolated in Victoria, Australia, between 1973 and 1998. J Gen Virol 81, 2511-8. Christenson, B. & Bottiger, M. (1994). Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 12, 129-33. Cichutek, K. (2000). DNA vaccines: development, standardization and regulation. Intervirology 43, 331-8. Cocks, B. G., Chang, C. C., Carballido, J. M., Yssel, H., de Vries, J. E. & Aversa, G. (1995). A novel receptor involved in T-cell activation. Nature 376, 260-3. Cohen, S., McGregor, I. & Carington, S. (1961). g-globulin and acquired immunity to human malaria. Nature 192, 733-87. Cutts, F. & Brown, D. (1995). The contribution of field tests to measles surveillance and control: a review of available methods. Reviews in Medical Virology 5, 35-40. Cutts, F., Soares, A., Jecque, A. V., Cliff, J., Kortbeek, S. & Colombo, S. (1990a. The use of evaluation to improve the Expanded Programme on Immunization in Mozambique. Bull World Health Organ 68, 199-208. Cutts, F. T., Smith, P. G., Colombo, S., Mann, G., Ascherio, A. & Soares, A. C. (1990b). Field evaluation of measles vaccine efficacy in Mozambique. Am J Epidemiol 131, 349-55. Cutts, F. T., Diallo, S., Zell, E. R. & Rhodes, P. (1991). Determinants of vaccination in an urban population in Conakry, Guinea. Int J Epidemiol 20, 1099-106. Cutts, F. T., Clements, C. J. & Bennett, J. V. (1997). Alternative routes of measles immunization: a review. Biologicals 25, 323-38. Dai, B., Chen, Z. H., Liu, Q. C., Wu, T., Guo, C. Y., Wang, X. Z., Fang, H. H. & Xiang, Y. Z. (1991). Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ 69, 415- 23. 149
Davenport, M. P., Quinn, C. L., Chicz, R. M., Green, B. N., Willis, A. C., Lane, W. S., Bell, J. I. & Hill, A. V. (1995). Naturally processed peptides from two disease-resistanceassociated H<strong>LA</strong>- DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the H<strong>LA</strong>-DR beta chain. Proc Natl Acad Sci U S A 92, 6567-71. Davis, R. M., Whitman, E. D., Orenstein, W. A., Preblud, S. R., Markowitz, L. E. & Hinman, A. R. (1987). A persistent outbreak of measles despite appropriate prevention and control measures. Am J Epidemiol 126, 438-49. Dawson, J. (1933). Cellular inclusions in cerebral lesions of lethargie encephalitis. Am J Pathol 9, 7-15. De-Coto, E. (1983). Evolution of the measles vaccination program in Costa Rica. Rev Infect Dis 38 (S-9), 1-13. Deseda-Tous, J., Cherry, J. D., Spencer, M. J., Welliver, R. C., Boyer, K. M., Dudley, J. P., Zahradnik, J. M., Krause, P. J. & Walbergh, E. W. (1978). Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child 132, 287-90. Dilraj, A., Cutts, F. T., de Castro, J. F., Wheeler, J. G., Brown, D., Roth, C., Coovadia, H. M. & Bennett, J. V. (2000). Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 355, 798-803. Dorig, R. E., Marcil, A., Chopra, A. & Richardson, C. D. (1993). The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305. Drillien, R., Spehner, D., Kirn, A., Giraudon, P., Buckland, R., Wild, F. & Lecocq, J. P. (1988). Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proc Natl Acad Sci U S A 85, 1252-6. Edmonson, M. B., Addiss, D. G., McPherson, J. T., Berg, J. L., Circo, S. R. & Davis, J. P. (1990). Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. Jama 263, 2467-71. Edmunds, W. J., Gay, N. J., Henao Restrepo, A. M., Olive, J. M. & Bele, O. (2001). Measles vaccination in Africa: by how much could routine coverage be improved? Vaccine 20, 16-8. 150
- Page 1 and 2:
UNIVERSITE JOSEPH FOURIER-GRENOBLE
- Page 3 and 4:
Je remercie le Dr Florence PRADEL e
- Page 5 and 6:
II.3 2. Les nouveaux vaccins……
- Page 7 and 8:
VI.3. La rougeole au Cameroun : Etu
- Page 9 and 10:
CHAPITRE I : LE VIRUS DE LA ROUGEOL
- Page 11 and 12:
I.Le virus de la rougeole 2. Classi
- Page 13 and 14:
I.Le virus de la rougeole 3. Struct
- Page 15 and 16:
I.Le virus de la rougeole 4. Struct
- Page 17 and 18:
I.Le virus de la rougeole 4. Struct
- Page 19 and 20:
I.Le virus de la rougeole 5. Cycle
- Page 21 and 22:
I.Le virus de la rougeole 5. Cycle
- Page 23 and 24:
Récepteur cellulaire Etat natif H
- Page 25 and 26:
I.Le virus de la rougeole 6. Pathol
- Page 27 and 28:
I.Le virus de la rougeole 6. Pathol
- Page 29 and 30:
I.Le virus de la rougeole 6. Pathol
- Page 31 and 32:
I.Le virus de la rougeole 6. Pathol
- Page 33 and 34:
II. La vaccination 1. Les vaccins i
- Page 35 and 36:
II. La vaccination 2. Les vaccins v
- Page 37 and 38:
Figure 6 : Souches vaccinales utili
- Page 39 and 40:
II. La vaccination 3. Les nouvelles
- Page 41 and 42:
II. La vaccination 3. Les nouvelles
- Page 43 and 44:
II. La vaccination 4. Position actu
- Page 45 and 46:
CHAPITRE III. ETUDES EPIDEMIOLOGIQU
- Page 47 and 48:
III. Etudes épidémiologiques 1. I
- Page 49 and 50:
III. Etudes épidémiologiques 2. P
- Page 51 and 52:
III. Etudes épidémiologiques 4. R
- Page 53 and 54:
III. Etudes épidémiologiques 4. R
- Page 55 and 56:
III. Etudes épidémiologiques 4. R
- Page 57 and 58:
III. Etudes épidémiologiques 5. P
- Page 59 and 60:
III. Etudes épidémiologiques 5. P
- Page 61 and 62:
IV. Epidémiologie moléculaire du
- Page 63 and 64:
IV. Epidémiologie moléculaire du
- Page 65 and 66:
IV. Epidémiologie moléculaire du
- Page 67 and 68:
IV. Epidémiologie moléculaire du
- Page 69 and 70:
IV. Epidémiologie moléculaire du
- Page 71 and 72:
IV. Epidémiologie moléculaire du
- Page 73 and 74:
V. La rougeole en Afrique 1. La rou
- Page 75 and 76:
V. La rougeole en Afrique 1. La rou
- Page 77 and 78:
V. La rougeole en Afrique 1. La rou
- Page 79 and 80:
Figure 8: Répartition des cas de r
- Page 81 and 82:
V. La rougeole en Afrique 2. La rou
- Page 83 and 84:
VI. Etude des souches Africaines du
- Page 85 and 86:
VI. Etude des souches Africaines du
- Page 87 and 88:
VI. Etude des souches Africaines du
- Page 89 and 90:
VI.1.4. Article 1 : Adaptation des
- Page 91 and 92:
1506 NOTES J. VIROL. FIG. 1. MV inf
- Page 93 and 94:
1508 NOTES J. VIROL. FIG. 3. Flow c
- Page 95 and 96:
VI. Etude des souches Africaines du
- Page 97 and 98:
Figure 9 : Répartition géographiq
- Page 99 and 100:
VI. Etude des souches Africaines du
- Page 101 and 102:
VI. Etude des souches Africaines du
- Page 103 and 104:
Measles virus strains circulating i
- Page 105 and 106: In 1983, measles viruses isolated i
- Page 107 and 108: obtained for the two 1983 isolates
- Page 109 and 110: easons. The available data for meas
- Page 111 and 112: Malvoisin E, Wild TF. 1990. Contrib
- Page 113 and 114: 106 0.005 100 82 100 86 98 New York
- Page 115 and 116: Table 1 : African measles strains u
- Page 117 and 118: VI.3. LA ROUGEOLE AU CAMEROUN : ETU
- Page 119 and 120: VI. Etude des souches Africaines du
- Page 121 and 122: VI. Etude des souches Africaines du
- Page 123 and 124: VI. Etude des souches Africaines du
- Page 125 and 126: VI. Etude des souches Africaines du
- Page 127 and 128: VI. Etude des souches Africaines du
- Page 129 and 130: CHAPITRE VII. DISCUSSION 122
- Page 131 and 132: VII. Discussion 1. Interaction viru
- Page 133 and 134: VII. Discussion 1. Interaction viru
- Page 135 and 136: VII. Discussion 2. Epidémiologie C
- Page 137 and 138: VII. Discussion 2. Epidémiologie f
- Page 139 and 140: CHAPITRE VIII. CONCLUSION ET PERSPE
- Page 141 and 142: ANNEXES 134
- Page 143 and 144: Consensus ATATCCATCA TGGGTCTCAA GGT
- Page 145 and 146: Consensus MTEIYDFDKS AWDIKGSIAP IQP
- Page 147 and 148: Consensus ATGTCACCGC AACGAGACCG GAT
- Page 149 and 150: Consensus MSPQRDRINA FYKDNPYPKG SRI
- Page 151 and 152: Consensus MGLKVNVSAI FMAVLLTLQT PAG
- Page 153 and 154: Aaby, P., Bukh, J., Lisse, I. M. &
- Page 155: Bouteille, M., Fontaine C., Vedrenn
- Page 159 and 160: Foege, W. (1971). Measles vaccinati
- Page 161 and 162: Griffin, D. E., Ward, B. J., Jaureg
- Page 163 and 164: Holt, E. A., Moulton, L. H., Siberr
- Page 165 and 166: Kok, P. W., Kenya, P. R. & Ensering
- Page 167 and 168: Markowitz, L. E., Albrecht, P., Rho
- Page 169 and 170: Norrby, E., Enders-Ruckles, G. & Me
- Page 171 and 172: Poland, G. A., Jacobson, R. M., Col
- Page 173 and 174: Siber, G. R., Werner, B. G., Halsey
- Page 175 and 176: Truong, A. T., Mulders, M. N., Gaut
- Page 177 and 178: WHO, World Health Organisation, Exp
- Page 179 and 180: TABLE DES ILLUSTRATIONS Figure 1. R
- Page 181: Abstract Despite the availability o